These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2496503)

  • 21. Regulation of immunoglobulin synthesis by human T cell subsets as defined by anti-D44 monoclonal antibody within the CD4+ and CD8+ subpopulations.
    Calvo CF; Bernard A; Huet S; Leroy E; Boumsell L; Senik A
    J Immunol; 1986 Feb; 136(4):1144-9. PubMed ID: 2935572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat.
    Elder ME; Maclaren NK
    J Immunol; 1983 Apr; 130(4):1723-31. PubMed ID: 6220066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of CD4 and CD8 surface expression on human thymocyte subpopulations by triggering through CD2 and the CD3-T cell receptor.
    Blue ML; Daley JF; Levine H; Branton KR; Schlossman SF
    J Immunol; 1989 Jan; 142(2):374-80. PubMed ID: 2783435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells.
    Bevan DJ; Chisholm PM
    Immunology; 1986 Dec; 59(4):621-5. PubMed ID: 2948906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery from chemically induced thymus atrophy starts with CD4- CD8- CD2high TcR alpha beta-/low thymocytes and results in an increased formation of CD4- CD8- TcR alpha beta high thymocytes.
    Pieters RH; Bol M; Lam BW; Seinen W; Bloksma N; Penninks AH
    Immunology; 1993 Apr; 78(4):616-22. PubMed ID: 8098700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
    Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
    Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic heart transplantation activates alloreactive NK cells.
    Petersson E; Ostraat O; Ekberg H; Hansson J; Simanaitis M; Brodin T; Dohlsten M; Hedlund G
    Cell Immunol; 1997 Jan; 175(1):25-32. PubMed ID: 9015185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nonlethal rat parvovirus infection suppresses rat T lymphocyte effector functions.
    McKisic MD; Paturzo FX; Gaertner DJ; Jacoby RO; Smith AL
    J Immunol; 1995 Oct; 155(8):3979-86. PubMed ID: 7561106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic and functional analysis of the cellular response in regional lymphoid tissue during an acute virus infection.
    Lynch F; Doherty PC; Ceredig R
    J Immunol; 1989 May; 142(10):3592-8. PubMed ID: 2785558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activities.
    Blue ML; Hafler DA; Daley JF; Levine H; Craig KA; Breitmeyer JB; Schlossman SF
    J Immunol; 1988 Jan; 140(2):376-83. PubMed ID: 2891768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The autonomy of CD8+ T cells in vitro and in vivo.
    Mason DW; Simmonds SJ
    Immunology; 1988 Oct; 65(2):249-57. PubMed ID: 2973432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones.
    Patel SS; Wacholtz MC; Duby AD; Thiele DL; Lipsky PE
    J Immunol; 1989 Aug; 143(4):1108-17. PubMed ID: 2526180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells.
    Lucas B; Engel A; Camus D; Haque A
    Cell Immunol; 1993 Aug; 150(1):59-71. PubMed ID: 8102089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A regulatory role for the CD4 and CD8 molecules in T cell activation.
    Schrezenmeier H; Fleischer B
    J Immunol; 1988 Jul; 141(2):398-403. PubMed ID: 2838548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engagement of CD4 and CD8 accessory molecules is required for T cell maturation.
    Ramsdell F; Fowlkes BJ
    J Immunol; 1989 Sep; 143(5):1467-71. PubMed ID: 2788186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
    Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
    J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts.
    Yankelevich B; Knobloch C; Nowicki M; Dennert G
    J Immunol; 1989 May; 142(10):3423-30. PubMed ID: 2654290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-2 and IL-4 can co-modulate the generation of cytotoxic T cells through CD8- CD4- splenic lymphocytes.
    Good MF; Powell LW; Halliday JW
    Immunology; 1989 Jun; 67(2):225-30. PubMed ID: 2568977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface phenotypes of human T cell lines generated after WGA- and PHA-stimulation.
    Siwicki JK; Skurzak H; Steffen JA
    Arch Immunol Ther Exp (Warsz); 1998; 46(1):9-16. PubMed ID: 9510940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.